Search Results - "Sanders, Gillian D."

Value of Information Analysis for Research Decisions—An Introduction: Report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force by Fenwick, Elisabeth, Steuten, Lotte, Knies, Saskia, Ghabri, Salah, Basu, Anirban, Murray, James F., Koffijberg, Hendrik (Erik), Strong, Mark, Sanders Schmidler, Gillian D., Rothery, Claire

“…Healthcare resource allocation decisions made under conditions of uncertainty may turn out to be suboptimal. In a resource constrained system in which there is…”
Get full text

Value of Information Analytical Methods: Report 2 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force by Rothery, Claire, Strong, Mark, Koffijberg, Hendrik (Erik), Basu, Anirban, Ghabri, Salah, Knies, Saskia, Murray, James F., Sanders Schmidler, Gillian D., Steuten, Lotte, Fenwick, Elisabeth

“…The allocation of healthcare resources among competing priorities requires an assessment of the expected costs and health effects of investing resources in the…”
Get full text

Oral Contraceptive Use and Risk of Breast, Cervical, Colorectal, and Endometrial Cancers: A Systematic Review by GIERISCH, Jennifer M, COEYTAUX, Remy R, MYERS, Evan R, URRUTIA, Rachel Peragallo, HAVRILESKY, Laura J, MOORMAN, Patricia G, LOWERY, William J, DINAN, Michaela, MCBROOM, Amanda J, HASSELBLAD, Vic, SANDERS, Gillian D

“…Oral contraceptives may influence the risk of certain cancers. As part of the AHRQ Evidence Report, Oral Contraceptive Use for the Primary Prevention of…”
Get full text

Systematic Review of the Incidence of Sudden Cardiac Death in the United States by Kong, Melissa H., MD, Fonarow, Gregg C., MD, Peterson, Eric D., MD, MPH, Curtis, Anne B., MD, Hernandez, Adrian F., MD, Sanders, Gillian D., PhD, Thomas, Kevin L., MD, Hayes, David L., MD, Al-Khatib, Sana M., MD, MHS

“…The need for consistent and current data describing the true incidence of sudden cardiac arrest (SCA) and/or sudden cardiac death (SCD) was highlighted during…”
Get full text

Oral Contraceptives and Risk of Ovarian Cancer and Breast Cancer Among High-Risk Women: A Systematic Review and Meta-Analysis by MOORMAN, Patricia G, HAVRILESKY, Laura J, MYERS, Evan R, GIERISCH, Jennifer M, COEYTAUX, Remy R, LOWERY, William J, PERAGALLO URRUTIA, Rachel, DINAN, Michaela, MCBROOM, Amanda J, HASSELBLAD, Vic, SANDERS, Gillian D

“…To estimate the risks of ovarian cancer and breast cancer associated with oral contraceptive (OC) use among women at elevated risk owing to mutations in…”
Get full text

Cost-Effectiveness of Implantable Cardioverter–Defibrillators by Sanders, Gillian D, Hlatky, Mark A, Owens, Douglas K

“…Eight clinical trials have evaluated the benefit of the implantable cardioverter–defibrillator (ICD) in patients with left ventricular dysfunction but no…”
Get full text

Assessing heterogeneity of treatment effect analyses in health-related cluster randomized trials: A systematic review by Starks, Monique Anderson, Sanders, Gillian D, Coeytaux, Remy Rene, Riley, Isaretta L, Jackson, 2nd, Larry R, Brooks, Amanda McBroom, Thomas, Kevin L, Choudhury, Kingshuk Roy, Califf, Robert M, Hernandez, Adrian F

“…Cluster-randomized trials (CRTs) are being increasingly used to test a range of interventions, including medical interventions commonly used in clinical…”
Get full text

Evaluating human papillomavirus vaccination programs by Taira, Al V, Neukermans, Christopher P, Sanders, Gillian D

“…Human papillomavirus (HPV) has been implicated as the primary etiologic agent of cervical cancer. Potential vaccines against high-risk HPV types are in…”
Get full text

Cost-Effectiveness of Screening for HIV in the Era of Highly Active Antiretroviral Therapy by Sanders, Gillian D, Bayoumi, Ahmed M, Sundaram, Vandana, Bilir, S. Pinar, Neukermans, Christopher P, Rydzak, Chara E, Douglass, Lena R, Lazzeroni, Laura C, Holodniy, Mark, Owens, Douglas K

“…The authors estimate that routine HIV screening in health care settings with a 1 percent prevalence of HIV infection costs about $15,000 per quality-adjusted…”
Get full text

New York Heart Association Class and the Survival Benefit from Primary Prevention Implantable Cardioverter Defibrillators: A Pooled Analysis of 4 Randomized Controlled Trials by Friedman, Daniel J., MD, Al-Khatib, Sana M., MD, MHS, Zeitler, Emily P., MD, MHS, Han, JooYoon, BS, Bardy, Gust H., MD, Poole, Jeanne E., MD, Bigger, J. Thomas, MD, Buxton, Alfred E., MD, Moss, Arthur J., MD, Lee, Kerry L., PhD, Steinman, Richard, AB, Dorian, Paul, MD, Cappato, Riccardo, MD, Kadish, Alan H., MD, Kudenchuk, Peter J., MD, Mark, Daniel B., MD, MPH, Inoue, Lurdes Y.T., PhD, Sanders, Gillian D., PhD

“…Background Primary prevention implantable cardioverter defibrillators (ICDs) reduce all-cause mortality by reducing sudden cardiac death. There are conflicting…”
Get full text

Remote Monitoring of Implantable Cardioverter Defibrillators versus Quarterly Device Interrogations in Clinic: Results from a Randomized Pilot Clinical Trial by AL-KHATIB, SANA M., PICCINI, JONATHAN P., KNIGHT, DAVID, STEWART, MARGARET, CLAPP-CHANNING, NANCY, SANDERS, GILLIAN D.

“…ICD: Remote Monitoring Versus Clinic Interrogations. Introduction: Remote monitoring is increasingly becoming the new standard of care for implantable…”
Get full text

Cost-effectiveness of a potential vaccine for human papillomavirus by Sanders, Gillian D, Taira, Al V

“…Human papillomavirus (HPV) infection, usually a sexually transmitted disease, is a risk factor for cervical cancer. Given the substantial disease and death…”
Get full text

Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient-Level Meta-Analysis by Shivakumar, Nishkala, Friedman, Daniel J, Fudim, Marat, Abraham, William T, Cleland, John G F, Curtis, Anne B, Gold, Michael R, Kutyifa, Valentina, Linde, Cecilia, Young, James, Tang, Anthony, Olivas-Martinez, Antonio, Inoue, Lurdes Y T, Sanders, Gillian D, Al-Khatib, Sana M

“…Data on the benefits of cardiac resynchronization therapy (CRT) in patients with severe heart failure symptoms are limited. We investigated the relative…”
Get full text

Developing the Next Generation of Leaders in Health Policy and Management: Lessons From an Undergraduate Student-Led Organization by Thomas, Charlotte, Sandhu, Sahil, Li, Josee, Sanders, Gillian D, Prvu Bettger, Janet

“…As health care continues to evolve, training the next generation of healthcare leaders is more important than ever. However, many university undergraduate…”
Get full text

Prioritization of Research Addressing Management Strategies for Ductal Carcinoma In Situ by GIERISCH, Jennifer M, MYERS, Evan R, SCHMIT, Kristine M, CROWLEY, Matthew J, McCRORY, Douglas C, CHATTERJEE, Ranee, COEYTAUX, Remy R, KENDRICK, Amy, SANDERS, Gillian D

“…Ductal carcinoma in situ is a common finding in women having mammography screening, and there is considerable uncertainty about the balance of harms and…”
Get full text

The Impact of Hearing Loss and Its Treatment on Health-Related Quality of Life Utility: a Systematic Review with Meta-analysis by Borre, Ethan D., Kaalund, Kamaria, Frisco, Nicholas, Zhang, Gloria, Ayer, Austin, Kelly-Hedrick, Margot, Reed, Shelby D., Emmett, Susan D., Francis, Howard, Tucci, Debara L., Wilson, Blake S., Kosinski, Andrzej S., Ogbuoji, Osondu, Sanders Schmidler, Gillian D.

“…Background Hearing loss significantly impacts health-related quality of life (QoL), yet the effects of current treatments on QoL utility remain uncertain. Our…”
Get full text

Overview of Cost-effectiveness Analysis by Sanders, Gillian D, Maciejewski, Matthew L, Basu, Anirban

“…This JAMA Guide to Statistics and Methods reviews the use of cost-effectiveness analysis to quantify the tradeoffs in costs, harms, and benefits of new health…”
Get full text

Model-Projected Cost-Effectiveness of Adult Hearing Screening in the USA by Borre, Ethan D., Dubno, Judy R., Myers, Evan R., Emmett, Susan D., Pavon, Juliessa M., Francis, Howard W., Ogbuoji, Osondu, Sanders Schmidler, Gillian D.

“…Background While 60% of older adults have hearing loss (HL), the majority have never had their hearing tested. Objective We sought to estimate long-term…”
Get full text

The potential cost-effectiveness of novel cord blood therapies in children with autism spectrum disorder by Borre, Ethan D, Myers, Evan, Hamilton Lopez, Marianne, Kurtzberg, Joanne, Shaz, Beth, Troy, Jesse, Sanders Schmidler, Gillian D

“…To model the long-term clinical and economic outcomes of potential cord blood therapy in autism spectrum disorder (ASD). Markov microsimulation of ASD over the…”
Get full text

Cost-Effectiveness Analysis 2.0 by Neumann, Peter J, Sanders, Gillian D

“…As prominent groups in U.S. health care ramp up use of cost-effectiveness analysis to measure and communicate the value of new drugs and other interventions,…”
Get full text